[go: up one dir, main page]

JPS609026B2 - Method for producing sulfur-containing pyridine derivative - Google Patents

Method for producing sulfur-containing pyridine derivative

Info

Publication number
JPS609026B2
JPS609026B2 JP2348875A JP2348875A JPS609026B2 JP S609026 B2 JPS609026 B2 JP S609026B2 JP 2348875 A JP2348875 A JP 2348875A JP 2348875 A JP2348875 A JP 2348875A JP S609026 B2 JPS609026 B2 JP S609026B2
Authority
JP
Japan
Prior art keywords
acid
methyl
pyridine
hydroxy
methylmercaptomethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2348875A
Other languages
Japanese (ja)
Other versions
JPS5170765A (en
Inventor
ザイコ オツト−
クルク ルドルフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742459334 external-priority patent/DE2459334A1/en
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of JPS5170765A publication Critical patent/JPS5170765A/en
Publication of JPS609026B2 publication Critical patent/JPS609026B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Description

【発明の詳細な説明】 本発明は、2−メチル−3−ヒドロキシ−4−エチルア
ミノメチル−5−メチル−メルカプトメチルーピリジン
(1)およびその酸付加塩の新規で有利な製法に関する
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a new and advantageous process for the preparation of 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methyl-mercaptomethyl-pyridine (1) and its acid addition salts.

前記化合物は価値ある薬理学的性質を示す。Said compounds exhibit valuable pharmacological properties.

従って、それらは医薬剤として使用され得る。特にそれ
らは脳波において好ましい作用を示す。前記化合物にい
くつかの製法が既知であるが、しかしながらこれらの方
法は各種の不利点を有する。すなわち1つにはそれらは
純粋な生成物を生成せず、そして1つには収量が不満足
である。今や前記化合物が特に本発明の新規な製法によ
り著しい高収率でそして高純度で得られることが見出さ
れた。本発明の対象は、一般式0 (式中Xは○またはSでありそしてRは日、1〜4個の
炭素原子を有するアルキルまたはペンジルである)のピ
リジン誘導体または前記化合物の塩をエチルアミンで処
理しそして所望により得られた塩基(1)を酸で処理し
てその生理学的に許容し得る酸付加塩の1種に変換する
ことを特徴とする、2ーメチルー3ーヒドロキシ−4−
エチルアミノメチル−5ーメチルメルカプトメチルーピ
リジン(1)およびその酸付加塩の製法である。
Therefore, they can be used as pharmaceutical agents. In particular, they show favorable effects on brain waves. Several methods are known for the preparation of said compounds, however these methods have various disadvantages. On the one hand, they do not produce pure products, and on the other hand, the yields are unsatisfactory. It has now been found that said compounds are obtainable in particularly high yields and in high purity by the novel process of the invention. The subject of the present invention is to prepare pyridine derivatives of the general formula 0, in which X is O or S and R is alkyl or pendyl having 1 to 4 carbon atoms, or salts of said compounds with ethylamine. 2-methyl-3-hydroxy-4-, characterized in that the base (1) obtained is converted by treatment with an acid into one of its physiologically acceptable acid addition salts.
This is a method for producing ethylaminomethyl-5-methylmercaptomethyl-pyridine (1) and its acid addition salt.

出発物質の1種すなわち2ーメチルー3ーヒドロキシ−
4−ヒドロキシメチル−5ーメチルメルカプトメチルー
ピリジン(ロ)(式中Xは○でありそしてRは日である
)は既知である。式0の他の化合物もまた例えば式D(
式中×は○でありそしてRは日である)の化合物をSO
C12と反応させて2−メチル−3ーヒドロキシ−4−
クロロメチル−5−メチルメルカプトメチルーピリジン
を生成させそして次いで式R−X−Na(例えばナトリ
ウムメチレート、硫化水素ナトリウムまたはナトリウム
ベンジルメルカプチド)のアルコレートまたはメルカプ
チドと反応せしめるような既知の方法で製造され得る。
エチルアミンとの式0の化合物の反応はそれが低沸点で
あるゆえに、所望により例えば窒素またはアルゴンのよ
うな不活性ガスを添加して加圧下(約10仇t以下)で
行なうのが適当である。
One of the starting materials, namely 2-methyl-3-hydroxy-
4-Hydroxymethyl-5-methylmercaptomethyl-pyridine (b) (wherein X is O and R is day) is known. Other compounds of formula 0 may also be used, such as those of formula D (
In the formula, × is ○ and R is day)
2-methyl-3-hydroxy-4- by reacting with C12
by known methods such as forming chloromethyl-5-methylmercaptomethyl-pyridine and then reacting with an alcoholate or mercaptide of the formula R-X-Na (e.g. sodium methylate, sodium hydrogen sulfide or sodium benzylmercaptide). can be manufactured.
Due to its low boiling point, the reaction of the compound of formula 0 with ethylamine is suitably carried out under pressure (less than about 10 tons), optionally with the addition of an inert gas such as nitrogen or argon. .

不活性溶媒も存在することができ、例えばメタノール、
エタノール、プロパノール、イソプロパノールまたはブ
タノールのようなアルコールである。反応温度は約20
qoないし約250こC好ましくは13000なし、し
230つ○が適当である。所望により得られた塩基(1
)は通常の方法によって酸と反応させて相当する酸付加
塩に転換し得る。
Inert solvents may also be present, e.g. methanol,
An alcohol such as ethanol, propanol, isopropanol or butanol. The reaction temperature is about 20
qo to about 250 C, preferably 13,000 or less, to 230 C is appropriate. Base obtained as desired (1
) can be converted into the corresponding acid addition salt by reaction with an acid by conventional methods.

この反応においては生理学的に許容し得る塩を生成する
ような酸が使用され得る。すなわち無機酸例えば硫酸、
硝酸、塩酸はたは臭化水素酸のよいなハロゲン化水素酸
、オルトりん酸のようなりん酸またはスルフアミン酸が
使用され、さらに有機酸特に脂肪族、脂環式、芳香脂肪
族、芳香族または複索環式のモノーまたはポリ塩基性カ
ルボン酸またはスルホン酸、例えばぎ酸、酢酸、プロピ
オン酸、ビバリン酸、ジェチル酢酸、マロン酸、こはく
酸、ピメリン酸、フマル酸、マレィン酸、乳酸、酒石酸
、りんご酸、〈えん酸、グルコン酸、アスコルビン酸、
安息香酸、サリチル酸、2ーフェニルプロピオン酸、ニ
コチン酸、ィソニコチン酸、メタンスルホン酸またはェ
タンスルホン酸、ェタンジスルホン酸、2−ヒドロキシ
ェタンスルホン酸、ベンゼンスルホン酸、p−トルェン
スルホン酸またはナフタリンモノおよびジスルホン酸も
また使用され得る。所望により式1の化合物の遊離塩基
がその塩から例えば水酸化ナトリウムまたはカルシウム
あるいは炭酸ナトリウムまたはカルシウムのような強塩
基で処理することによって遊離され得る。
Acids that produce physiologically acceptable salts may be used in this reaction. i.e. inorganic acids such as sulfuric acid,
Hydrohalic acids such as nitric acid, hydrochloric acid or hydrobromic acid, phosphoric acids such as orthophosphoric acid or sulfamic acids are used, as well as organic acids, especially aliphatic, cycloaliphatic, araliphatic and aromatic acids. or polycyclic mono- or polybasic carboxylic or sulfonic acids, such as formic acid, acetic acid, propionic acid, bivalic acid, diethyl acetic acid, malonic acid, succinic acid, pimelic acid, fumaric acid, maleic acid, lactic acid, tartaric acid , malic acid, < enoic acid, gluconic acid, ascorbic acid,
Benzoic acid, salicylic acid, 2-phenylpropionic acid, nicotinic acid, isonicotinic acid, methanesulfonic acid or ethanesulfonic acid, ethanedisulfonic acid, 2-hydroxyethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid or naphthalene mono and disulfonic acids may also be used. If desired, the free base of a compound of formula 1 can be liberated from its salt by treatment with a strong base such as, for example, sodium or calcium hydroxide or sodium or calcium carbonate.

本発明による方法は塩基(1)の化合物およびその酸付
加塩を著しい高収率でそして著しく純粋な形態(実際上
副生成物を含まない)で生成する。このようにして得ら
れた化合物はさらに精製することないこ通常の医薬製剤
に直接転換され得る。実施例 1 メタノール750机中2ーメチルー3−ヒドロキシ−4
−メトキシメチルー5ーメチルメルカプトメチルーピリ
ジン150夕の溶液を礎洋付オートクレープ中で液体エ
チルアミンと一緒に14000に6時間加熱する。
The process according to the invention produces the compounds of base (1) and their acid addition salts in extremely high yields and in extremely pure form (virtually free of by-products). The compounds thus obtained can be converted directly into conventional pharmaceutical preparations without further purification. Example 1 2-methyl-3-hydroxy-4 in methanol 750 units
A solution of 150 ml of methoxymethyl-5-methylmercaptomethyl-pyridine is heated with liquid ethylamine to 14,000° C. for 6 hours in a submerged autoclave.

この混合物を濃縮し、エタノール性塩酸300の‘を残
留物に添加し、混合物を冷却し、そして得られた2−メ
チル−3−ヒドロキシ−4−エチルアミノメチル−5−
メチルメルカプトメチルーピリジンジ塩酸塩を吸引ろ過
しそして少量のメタノールおよびエーテルで洗浄する(
融点23800)。実施例 2 縄杵付オ−トクレープ中で液体エチルアミン1.8そお
よび氷袷メタノール1.8その混合物を2−メチル−3
−ヒドロキシ−4−ヒドロキシメチル−5ーメチルメル
カプトメチルーピリジン1k9に添加する。
The mixture was concentrated, 300' of ethanolic hydrochloric acid was added to the residue, the mixture was cooled and the resulting 2-methyl-3-hydroxy-4-ethylaminomethyl-5-
The methylmercaptomethyl-pyridine dihydrochloride is filtered off with suction and washed with a small amount of methanol and ether (
Melting point 23800). Example 2 In an autoclave with a rope pestle, a mixture of 1.8 g of liquid ethylamine and 1.8 g of methanol was mixed with 2-methyl-3
-Hydroxy-4-hydroxymethyl-5-methylmercaptomethyl-pyridine 1k9.

オートクレープ中に1瓜tの窒素圧を与えた後に前記混
合物を鷹拝しながら6時間150℃に加熱する。混合物
を冷却し、濃縮し、残留物をィソプロパノールに溶解さ
せそして再び濃縮する。得られた粗塩基をメタノール中
に溶解させ、この溶液を木炭で処理しそしてろ過する。
塩酸をpH1.5になるまでろ液に加える。ジ塩酸塩が
冷却下に晶出する(融点238℃)。実施例 3 2−メチル−3ーヒドoキシー4ーメルカプトメチルー
5ーメチルメルカプトメチルーピリジン645の9、エ
タノール2泌およびエチルアミン2の‘の混合物を封管
中で150ooに6時間加熱する。
After applying 1 ton of nitrogen pressure in the autoclave, the mixture is heated to 150° C. for 6 hours under pressure. The mixture is cooled, concentrated, the residue is dissolved in isopropanol and concentrated again. The crude base obtained is dissolved in methanol, the solution is treated with charcoal and filtered.
Add hydrochloric acid to the filtrate until pH 1.5. The dihydrochloride crystallizes out on cooling (melting point 238° C.). Example 3 A mixture of 2-methyl-3-hydroxy-4-mercaptomethyl-5-methylmercaptomethyl-pyridine 645, ethanol 2, and ethylamine 2' is heated to 150 oo for 6 hours in a sealed tube.

前記混合物を濃縮し、残留物をシリカゲル上クロロホル
ム/メタノール/酢酸エチル(7:2:1)でクロマト
グラフィー処理しそして2ーメチルー3ーヒドロキシー
4ーエチルアミノメチル一5−メチルメルカプトメチル
ーピリジンを得る(融点鼠〜6500)。実施例 4 封管中2−メチル−3−ヒドロキシ−4・5ービス−(
メチルメルカプトメチル)−ピリジン690の9、イソ
プロパノール2の【およびエチルアミン2の‘の混合物
を220午0に6時間加熱する。
The mixture is concentrated and the residue is chromatographed on silica gel with chloroform/methanol/ethyl acetate (7:2:1) to give 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine ( Melting point ~6500). Example 4 2-methyl-3-hydroxy-4,5-bis-(
A mixture of methyl mercaptomethyl)-pyridine, 690 parts, isopropanol, 2 parts, and ethylamine, 2 parts', is heated to 220:00 for 6 hours.

前記混合物を濃縮し、シリカゲル上でクロマトグラフィ
ー処理しそして2ーメチルー3−ヒドロキシ−4ーエチ
ルアミノメチル−5−メチルメルカプトメチルーピリジ
ンを得る(融点64〜65oo)実施例 52−メチル
−3ーヒドロキシー4ーベンジルメルカプトメチル一5
ーメチルメルカプトメチルーピリジンを実施例4と同様
に処理してそれと同一の最終生成物を得る。
The mixture is concentrated and chromatographed on silica gel to give 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine (melting point 64-65oo) Example 52-Methyl-3-hydroxy-4 -benzylmercaptomethyl-5
-Methylmercaptomethyl-pyridine is treated analogously to Example 4 to give the same final product.

Claims (1)

【特許請求の範囲】 1 式II ▲数式、化学式、表等があります▼ (式中XはOまたはSでありそしてRはH、1〜4個の
炭素原子を有するアルキルまたはベンジルである)のピ
リジン誘導体またはその酸付加塩をエチルアミンで処理
しそして所望により得られる塩基(I)を酸で処理して
その生理学的に許容し得る酸付加塩に変換することを特
徴とする、2−メチル−3−ヒドロキシ−4−エチルア
ミノメチル−5−メチルメルカプトメチル−ピリジン(
I)およびその酸付加塩の製法。
[Scope of Claims] 1 Formula II ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (wherein X is O or S and R is H, alkyl or benzyl having 1 to 4 carbon atoms) A 2-methyl- 3-Hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine (
I) and its acid addition salt production method.
JP2348875A 1974-12-16 1975-02-27 Method for producing sulfur-containing pyridine derivative Expired JPS609026B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2459334.8 1974-12-16
DE19742459334 DE2459334A1 (en) 1968-12-05 1974-12-16 Cerebrally active pyridine derivs prepn - viz 2-methyl-3-hydroxy-4-ethylaminomethyl-5- methylthiomethyl-pyridine and salts

Publications (2)

Publication Number Publication Date
JPS5170765A JPS5170765A (en) 1976-06-18
JPS609026B2 true JPS609026B2 (en) 1985-03-07

Family

ID=5933500

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2348875A Expired JPS609026B2 (en) 1974-12-16 1975-02-27 Method for producing sulfur-containing pyridine derivative

Country Status (3)

Country Link
JP (1) JPS609026B2 (en)
CH (1) CH602651A5 (en)
HU (1) HU170193B (en)

Also Published As

Publication number Publication date
JPS5170765A (en) 1976-06-18
HU170193B (en) 1977-04-28
CH602651A5 (en) 1978-07-31

Similar Documents

Publication Publication Date Title
KR20010053294A (en) Method for producing ortho-alkylated benzoic acid derivatives
SU481155A3 (en) Production method - (furyl-methyl) morphinans
TW201912656A (en) Method for preparing sugammadex sodium and crystalline form thereof
SK14672001A3 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
CN113214223B (en) Preparation method of Voranolan fumarate impurity
JPS609026B2 (en) Method for producing sulfur-containing pyridine derivative
Hünig et al. A convenient synthesis of 2, 2', 6, 6'-Tetramethyl-4, 4'-bipyridine and its oxidation to 2, 2', 6, 6'-Tetracarboxy-4, 4'-bipyridine
CA1068710A (en) Preparation of 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine and its acid addition salts
US3583992A (en) 1-methyl-d-lysergic acid-dihydroxy-alkyl-amides
JPS6028838B2 (en) Method for producing nitrogen-containing polycyclic compound
JP2815654B2 (en) Novel 4-substituted-3,5-dimethylpicolinic acid compound and method for producing the same
JPS602293B2 (en) Glycyrrhetinic acid derivative
CN111718295B (en) Preparation method of high-purity milrinone
US3136779A (en) 1-propargyl-2-methyl-3-phenyl-3-propionyloxy-pyrrolidines
CN111718292B (en) Milrinone intermediate compound
EP0013153B1 (en) 6-amino pyridine carboxylic acid derivatives, a process for their preparation and pharmaceutical compositions containing them
CN108101892A (en) A kind of Chrysin non-natural amino acid derivative and its preparation method and application
KR950008527B1 (en) A process for the preparation of pyridine derivatives
JPH01163175A (en) Furan-2-one derivative
CN119143619A (en) Synthesis method of phenylglycine derivative
KR100516383B1 (en) New manufacturing process of dihydrocarbostyril derivatives
KR20250014615A (en) Process for preparing vonoprazan fumarate
US3120531A (en) 10-bromoyohimbine alkaloids
KR820001121B1 (en) Process for preparing 2-amino-methyl pyrolidine
KR100297802B1 (en) Method for preparing 2- (3-trifluoromethyl) anilinonicotinic acid 2- (N-morpholine) ethyl.